Pediatric diabetes and pediatric diabetic nephropathy rates significantly increase at age 12.
Melissa Glim
Advertisement
Articles by Melissa Glim
New insulin caused blood sugar levels to fall in mouse models, creating hope for improved treatment of diabetes.
Maturity-onset diabetes of the young is a rare form of diabetes caused by a range of genetic mutations that interrupt beta cell function.
Researchers seek to improve treatment for autoimmune diseases, including rheumatoid arthritis, gout, Crohn's disease, and lupus.
Advertisement
Latest Updated Articles
How Can Adherence be Improved in Autoimmune Diseases?Published: August 21st 2015 | Updated:
Research Targets Improved Insulin DevelopmentPublished: April 10th 2016 | Updated:
Oral Medications May Cause More Harm in Rare Form of DiabetesPublished: March 29th 2016 | Updated:
Juvenile Diabetes Rates IncreasePublished: May 5th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
4
Study Shows Growing Confidence in Cell and Gene Therapies Across the Care Continuum
5
